InvestSMART

Prana Biotechnology Limited (ASX: PBT) - Announcements

Current share price for PBT : $0.049 0.002 (4.26%)+

ASX company news and announcements for Prana Biotechnology Limited (PBT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Prana Biotechnology Limited (PBT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Prana Biotechnology Limited (PBT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Prana Biotechnology Limited (PBT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Appendix 4C - quarterly 28 Oct 2009 5:46PM $0.190 $0.049 fallen by 74.21%
- Prana Secures $6 million Additional Financing 9 Sep 2009 9:12AM $0.235 $0.049 fallen by 79.15%
- Preliminary Final Report 26 Aug 2009 3:42PM $0.230 $0.049 fallen by 78.70%
- Prana Allowed Key Patent for PBT2 in the United States 12 Aug 2009 2:33PM $0.240 $0.049 fallen by 79.58%
- Prana is Granted Key Patent by European Patent Office 5 Aug 2009 9:27AM $0.220 $0.049 fallen by 77.73%
- Appendix 4C - quarterly 30 Jul 2009 5:07PM $0.175 $0.049 fallen by 72%
- Appendix 4C - Quarterly Report 30 Apr 2009 10:30AM $0.185 $0.049 fallen by 73.51%
- Study Corroborates Prana`s AD Strategy 2 Apr 2009 9:42AM $0.195 $0.049 fallen by 74.87%
- Prana`s PBT2 Prevents Synaptic Loss in Alzheimer`s Disease 11 Mar 2009 9:31AM $0.200 $0.049 fallen by 75.50%
- Appendix 4D 18 Feb 2009 5:10PM $0.270 $0.049 fallen by 81.85%
- Appendix 4C - quarterly 30 Jan 2009 12:02PM $0.295 $0.049 fallen by 83.39%
- Prana Provides Update on Research and Development Programs 28 Nov 2008 10:40AM $0.300 $0.049 fallen by 83.67%
- Appendix 4C 30 Oct 2008 5:24PM $0.410 $0.049 fallen by 88.05%
- Appendix 4E Preliminary Financial Report 28 Aug 2008 6:14PM $0.460 $0.049 fallen by 89.35%
- Appendix 4C - quarterly 31 Jul 2008 5:24PM $0.425 $0.049 fallen by 88.47%
- The Lancet Neurology Publishes Clinical Results of PBT2 30 Jul 2008 9:21AM $0.480 $0.049 fallen by 89.79%
- Neuron to Publish Pranas PBT2 Preclinical Research 10 Jul 2008 10:15AM $0.390 $0.049 fallen by 87.44%
- $7 million Placement to Fund Research Programs 21 May 2008 9:59AM $0.400 $0.049 fallen by 87.75%
- PNAS Publication Describes New Class of Anti-Amyloid Drugs 13 May 2008 9:43AM $0.450 $0.049 fallen by 89.11%
- Novel drug candidates discovered for Parkinsons Disease use 6 May 2008 2:52PM $0.420 $0.049 fallen by 88.33%
- Trading Halt 6 May 2008 11:50AM $0.420 $0.049 fallen by 88.33%
- Appendix 4C 24 Apr 2008 4:48PM $0.430 $0.049 fallen by 88.60%
- Prana to be Featured in Alzheimer`s Disease Conference Call 14 Mar 2008 12:48PM $0.480 $0.049 fallen by 89.79%
- Prana responds to Press comments 4 Mar 2008 4:08PM $0.575 $0.049 fallen by 91.48%
- Success in Phase IIa Clinical Trial of PBT2 26 Feb 2008 10:05AM $0.540 $0.049 fallen by 90.93%

251 - 275 of 331 results

Page 11 of 14

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.